Last edition
News about "Oxybutynin hydrochloride"
Marksans Pharma’s UK subsidiary Relonchem has received MHRA approval for Oxybutynin hydrochloride 2.5mg/5ml Oral Solution, strengthening the company’s presence in the UK generics market across key therapeutic areas.
Oxybutynin Hydrochloride | 19/06/2025 | By Abha | 163
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members